Inhibitory deficit in schizophrenia is not necessarily a GABAergic deficit (Q35018695)

5 August 2017

1 reference

title

Inhibitory deficit in schizophrenia is not necessarily a GABAergic deficit (English)

1 reference

5 August 2017

0 references

Diogo R Lara

1

1 reference

5 August 2017

publication date

1 June 2002

1 reference

Cellular and Molecular Neurobiology

5 August 2017

published in

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

239-247

1 reference

GABAB antagonists diminish the inhibitory gating of auditory response in the rat hippocampus.

5 August 2017

cites work

1 reference

12 December 2020

Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenil.

1 reference

12 December 2020

Enhancement of prepulse inhibition after blockade of GABA activity within the superior colliculus

1 reference

12 December 2020

The adenosine A1 receptor agonist N6-cyclopentyladenosine blocks the disruptive effect of phencyclidine on prepulse inhibition of the acoustic startle response in the rat.

1 reference

12 December 2020

Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions

1 reference

12 December 2020

Stereoselective Antagonism of Phencyclidine's Discriminative Properties by Adenosine Receptor Agonists

1 reference

12 December 2020

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

12 December 2020

Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia

1 reference

12 December 2020

Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum

1 reference

12 December 2020

Schizophrenia, Sensory Gating, and Nicotinic Receptors

1 reference

12 December 2020

The role and regulation of adenosine in the central nervous system

1 reference

12 December 2020

Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat.

1 reference

12 December 2020

Allopurinol augmentation for poorly responsive schizophrenia

1 reference

12 December 2020

Critical review of GABA-ergic drugs in the treatment of schizophrenia

1 reference

12 December 2020

Therapeutic benefit of adjunctive dipyridamole in schizophrenia is probably due to adenosine-glutamate interactions

1 reference

12 December 2020

Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist

1 reference

12 December 2020

Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients

1 reference

12 December 2020

Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man.

1 reference

12 December 2020

Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications

1 reference

12 December 2020

Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks.

1 reference

12 December 2020

GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder

1 reference

12 December 2020

Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain

1 reference

12 December 2020

Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia

1 reference

12 December 2020

Schizophrenia: a purinergic hypothesis

1 reference

12 December 2020

Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications

1 reference

12 December 2020

Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation

1 reference

12 December 2020

Levels of endogenous adenosine in rat striatum. I. Regulation by ionotropic glutamate receptors, nitric oxide and free radicals

1 reference

12 December 2020

New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism

1 reference

12 December 2020

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

12 December 2020

Interaction between A1 adenosine and class II metabotropic glutamate receptors in the regulation of purine and glutamate release from rat hippocampal slices

1 reference

12 December 2020

The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia

1 reference

12 December 2020

Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

1 reference

12 December 2020

Amygdaloid N-methyl-D-aspartate and gamma-aminobutyric acid(A) receptors regulate sensorimotor gating in a dopamine-dependent way in rats

1 reference

12 December 2020

Release of adenosine by activation of NMDA receptors in the hippocampus.

1 reference

12 December 2020

Valproate and the symptomatic treatment of schizophrenia spectrum patients

1 reference

12 December 2020

Baclofen in Tardive Dyskinesia Patients Maintained on Neuroleptics

1 reference

12 December 2020

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

1 reference

12 December 2020

Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus

1 reference

12 December 2020

Disinhibitory effect of phencyclidine in the hippocampus in vitro: PCP receptors implicated

1 reference

12 December 2020

Do high or low doses of anxiolytics and hypnotics affect mismatch negativity in schizophrenic subjects? An EEG and MEG study

1 reference

12 December 2020

Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors.

1 reference

12 December 2020

Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: reversal by haloperidol

1 reference

12 December 2020

Adenosine permeation of a dynamic in vitro blood-brain barrier inhibited by dipyridamole

1 reference

12 December 2020

Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal

1 reference

12 December 2020

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

12 December 2020

Glutamate receptor dysfunction and schizophrenia

1 reference

12 December 2020

The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects

1 reference

12 December 2020

Adenosine A1 and A2 receptor agonists significantly prevent the electroencephalographic effects induced by MK-801 in rats

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020759615977

1 reference

Dimensions Publication ID

5 August 2017

1004943271

0 references

1 reference